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For many years attempts have been made to passively transfer allergic
eczematous contact-type hypersensitivity in man. The general opinion among
dermatologists and immunologists appears to be that thus far these attempts in
man have failed and that the reports of occasional successful transfers can be
explained as due to technical errors, inadequate controls, etc. At least this was
the conclusion in the most recent review of the pertinent literature in 1947
(Leider and Baer (1)).
Further work in this field appeared worthwhile on the basis of the publications
of Landsteiner and Chase (2) and of H. S. Lawrence (3). The stimulating work
of Landsteiner and Chase on experimental animals indicated that both the
tuberculin-type and the contact-type allergic hypersensitivity could be passively
transferred by injecting suspensions of white cells prepared from peritoneal
exudates of sensitive donor animals into the blood circulation of non-sensitive
recipient animals. The subsequent work of H. S. Lawrence (3) was a logical out-
growth of the experiments with animals of Landsteiner and Chase and led to
the first successful passive transfer of tuberculin-type sensitivity in man. Law-
rence injected viable white cells, from the blood of donor patients without
active tuberculous disease, but whose skin was sensitive to tuberculin, intra-
cutaneously into the skin of recipient patients who had previously been proven
not to be skin sensitive to tuberculin. By this technic he was able to bring about
a temporary passive local skin sensitivity and with larger amounts of leucocytes
even a generalized skin sensitivity to tuberculin in the recipient subjects.
In the experiments which are to be reported here, the passive transfer technic
worked out by H. S. Lawrence was utilized in attempts to passively transfer
allergic eczematous contact-type hypersensitivity in man. This technic in general
corresponds to that published by Lawrence, but some changes were made after
personal communication with this author.
EXPERIMENTAL
Technic
Ninety to 120 cc. of whole venous blood was drawn from the donor patient
who had been proved to have an allergic eczematous contact-type hypersensi-
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tivity to a specific allergen. The blood was placed in potato tubes containing 1.0
ml. of a 100 mg. % heparin2 solution for each 15 ml. of blood and the tubes were
gently shaken. 0.8 to 1.0 ml. of bovine fibrinogen solution3 was added for each
10 ml. of blood and each tube was then inverted twice.
Ten ml. aliquots of the blood containing heparin and fibrinogen were then
transferred to conical centrifuge tubes and these were placed in a water bath at
37°C. for approximately 20—GO minutes (the proper time to terminate the water
bath is when the white cells begin to settle on the sedimented red cells and when
the supernatant plasma assumes a yellowish color). The supernatant plasma was
then transferred by capillary pipette to specially constructed centrifuge tubes
with capillary tips which are graduated to permit measurement of the quantity
of white cells present. After centrifuging at 1800 r.p.m. for 22 minutes, the cell-
free plasma was decanted and by means of a capillary pipette the packed leuco-
cytes were taken off the red cell precipitate at the bottom of the tube and were
then washed and resuspended in 2.0 ml. of Tyrode's4 washing solution.
The cell suspensions from the several tubes were then pooled in one capillary-
tipped centrifuge tube and were centrifuged at 1400 r.p.m. for 15 minutes. The
supernatant was decanted and the washing in Tyrode's solution and centrifuga-
tion was repeated at 1400 r.p.m. for 15 minutes. The supernatant was again
decanted, the volume of the packed leucocytes was read (average 0.08—0.14 ml.
per 90 ml. of blood) and the leucocytes were resuspended in 0.15—0.25 ml. of
sterile Tyrode's solution (not containing heparin).
With a 23 gauge needle and tuberculin syringe the white cell suspension was
injected into the flexor aspect of the forearm of a recipient at a level slightly
deeper than is customary in intracutaneous injections. The recipients were
patients who were suffering from one of a variety of dermatoses, including ec-
zematous dermatitis, nummular eczema, urticaria and atopic dermatitis, etc;
2 Heparin—sterile solution (1,000 units per cc.) obtained from Connaught Med. Research
Labs., Univ. of Toronto, in 10 ml. vials. 10 in!. heparin is added to 26 cc. sterile saline solu-
tion and to prevent clottinthis is used per 15 ml. of whole blood.
Fibrinogen—Bovine fibrinogen (Armour), fraction 1, containing approximately 45
mg. fibrinogen per ml. Seven grams of bovine fibrinogen powder is dissolved in 150 cc.
distilled water and placed in a water bath for 20 minutes at 37°C. This is sterilized by
Seitz-filter (100 cc. funnel) and usually yields about 85—110 cc. fibrinogen solution which is
stored in a refrigerator. The solution is cultured at weekly intervals to rule out contamina-
tion. The amount of fibrinogen which is used for each 10cc. of blood varies with the different
batches of fibrinogen. Therefore each batch has to be standardized individually as follows:
60 ml. whole blood is drawn from a normal subject and is placed in sterile potato tubes con-
taining 1.0 ml. of a 100 mg. % heparin solution per 15 cc. of whole blood. The potato tubes
are gently shaken and the contents are transferred in 10 ml. aliquots into 6 sterile centrifuge
tubes containing 0.7, 0.8, 0.9, 1.0, 1.1 and 1.2 ml. of sterile fibrinogen solution respectively.
The centrifuge tubes are inverted twice and are placed in a water bath at 37°C. for 20 to
60 minutes. The remaining part of the procedure consists of individual centrifugation,
washing with Tyrode's solution, etc. as outliaed below. That quantity of fibrinogen solution
which is just below that which causes clotting is the one which is used for each 10 cc. of whole
blood in all tests with the particular batch of fibrinogen.
The pH of Tyrode's solution used was 7.3—7.8 after autoclaving. Tyrode's washing solu-
tion consists of Tyrode's solution 11 ml. and heparin solution 4 ml.
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as a rule they were patch tested prior to the transfer test to make certain that
they had no preexisting (active) allergic eczematous sensitivity to the allergen
with which passive transfer was being attempted. Control sites were prepared
simultaneously as described below.
The skin sites at which the white cell suspension were injected showed a nodular
induration and erythema for a period of at least two days, but in most instances
for several more days and at times even longer. A patch test with the eczemato-
genie allergen to which the donor was known to be sensitive was applied to the
recipient's passive transfer site as soon as the erythema had subsided and even
when the nodule persisted. The patch test usually was left in place for 2 days
and in a few cases up to 7 days.
In every recipient a control site on the flexor aspect of the upper arm was
patch tested at the same time. This site had been prepared by injecting it with
Tyrode's solution not containing any white cells. In a few of the patients a patch
test was also applied to a second control site on the flexor aspect of the other
forearm which had been prepared by injecting a white cell suspension from the
blood of a donor known not to be sensitive to the allergen involved in
the particular experiment.
All the procedures which involved preparation and injection of the white cell
suspensions were, of course, carried out under aseptic conditions. The total time
interval between the drawing of the blood from the donor and the injection of
the white cell suspension into the recipient was 3—ft hours.
The tests to date have been carried out with white cell suspensions from 27
patients with allergic eczematous contact-type sensitivity. Three of these donors
were strongly sensitive to two allergens and the recipients of their white cell
suspensions were therefore patch tested with both. The allergens to which the
donors were sensitive and to which passive transfer was attempted were as
follows:
Patients
Paraphenylenediamine, 2% in petrolatum 6
Nickel sulfate, 5% aqueous solution 7
Benzocaine, 5% in petrolatum 5
Turpentine, 50% in mineral oil 4
Ragweed oleoresin, 1:10 in acetone (Graham Labs.) 3
Mercury bichloride, 0.1% aqueous solution 1
Aquaphor®, as is 1
Ammoniated mercury, 10% in petrolatum 1
Surfacaine®, as is 1
RESULTS
The passive transfer tests were unequivocally negative in 21 of the 27 re-
cipients. In 2 the reaction at the passive transfer site was questionable (1 with
turpentine and 1 with nickel sulfate) and again was questionable on retesting 5
months later. However in 4 patients the reaction at the passive transfer site
was positive. The details of these four cases are presented in table I.
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COMMENT
Our results clearly indicate that in the large majority of tests, namely in 23 of
27, there was no evidence indicating passive transfer of eczematous sensitivity.
The cases which we wish to discuss here in greater detail are those four in which
the reaction at the passive transfer site was positive. For here the decisive
question arises whether the positive reactions are an indication that passive
transfer of eczematous sensitivity actually took place. In favor of such a hy-
TABLE I
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pothesis is the fact that three of these four patients had been patch tested with
the allergen in question prior to the passive transfer tests and had had negative
reactions (see table I). However, some doubt arises on this score, because, when
patch tested after the cell transfer all four recipients were as sensitive or almost
as sensitive at the control site as at the cell injected site. In the event of passive
transfer one would have expected a stronger reaction at the cell injected site
than at the control site. Moreover, when these four patients were retested 2 to 8
months after the original transfer tests they were still just as sensitive to the
allergen as they had been at the time of the transfer experiment.
Had these patients undergone pas.sive sensitization which then persisted for a
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period of 2 to 8 months? In passive transfer tests of urticarial sensitivity accord-
ing to the Prausnitz-Kuestner technic the passive sensitization often lasts over
a period of many weeks, but it is confined to the site of injection and the site is
usually exhausted after one exposure to the homologous allergen. H. S. Lawrence
in his passive transfer tests of tuberculin-type sensitivity, using the technic de-
veloped by him and employed by us in our experiments, has observed localized
and in some cases also generalized cutaneous sensitivity in the recipient. The
sensitivity was localized when small amounts of white blood cells (about 005
ml.) were used and were injected in a single site on the forearm. Generalized
cutaneous sensitivity could be induced by using 0.1 ml. or greater amounts of
leucocytes, injected into multiple sites in the shoulder region of the recipients who
would then be tested in an unprepared site on the opposite forearm. Passive
sensitization persisted as long as 5 months (4) in an isolated instance5. Since there
is no previous experience with Lawrence's technic when applied to transfer ex-
periments of eczematous sensitivity, it is not possible to draw any definite con-
clusions either in favor of or against passive sensitization from the persistence of
sensitivity in the four recipients in our series. Nevertheless on the basis of all
the available information on passive transfer by other technics and in other types
of allergic sensitivity one would be inclined to consider it unlikely that passively
transferred sensitivity would have persisted up to 8 months.
Another piece of evidence which speaks against passive sensitization is the
fact that although 9 different eczematogenic allergens were used in the 27 re-
cipients, turpentine was the allergen in 3 of the 4 cases which showed positive
reactions. Is it possible that the 4 subjects with positive reactions acquired an
active rather than a passive sensitization? Perhaps the turpentine solution used
by us had a particularly high sensitizing potential. In order to investigate this
possibility we carried out patch tests with the identical turpentine solution in 8
women, who otherwise were not involved in the present experiments. Five of these
8 women were retested 2 or more months later with the same turpentine solu-
tion and in these five there were no significant differences in the results of the
first tests and the retests. Thus there was no evidence in this very small control
group that patch testing with this turpentine solution was capable of inducing
active sensitization. Nevertheless we cannot rule out the occurrence of active
sensitization in our four subjects with positive reactions in the transfer tests and
the decision whether their positive test reactions were based on active or passive
sensitization must be held in abeyance.
If one assumes that the reactions in these four subjects were due to active rather
than passive sensitization this would mean that four of the 27 cell recipients de-
veloped sensitizations from the allergenic exposure entailed in the patch tests,
although all 9 allergenic substances were applied in the concentrations which are
There were two medical students with passively acquired sensitivity to tuberculin,
who remained tuberculin positive for 1 year. One of them reverted then to the tuberculin
negative state. In both these instances the possibility of active sensitization during ward
exposure to patients with tuberculous disease in the year following cellular transfer cannot
be excluded (4).
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routinely employed for patch testing. As a matter of fact, there was a fifth cell
recipient who became sensitized in the course of these tests. At first his patch
tests with paraphenylenediamine were negative at the cell injected site and at 2
control sites. However, 2 weeks after application of the patch tests (i.e., 1 week
after their removal and 3 weeks after cell injection) all three sites suddenly flared
up in an cezematous reaction, indicating that this patient probably became ac-
tively sensitized to the paraphenylenediamine—unless one wishes to make the
most unlikely assumption that the flare-ups were delayed evidence of passive
sensitization.
Obviously, if in everyday patch testing with turpentine and other common
allergens there was a danger of sensitizing 5 of 27 patients, i.e., one out of every
5 to 6 patients, the patch test could not be used as a routine testing procedure in
clinical dermatology.
Again assuming that we are here dealing with active sensitization, it is possible
that our results are based on statistically explainable "freak" occurrence. How-
ever, this unusually high incidence of active sensitizations from patch testing
brings up the interesting possibility that, while we may not have passively trans-
ferred the eczematous sensitization to turpentine and to ammoniated mercury,
we may have transferred in the white cell suspensions a hitherto unknown and un.-
suspected factor which increases the capacity of skin to become actively sensitized
to the specific allergen to which the donor of the white cells is sensitive. There
are a great number of factors which are known to influence the incidence of ec-
zematous sensitization. Some of these pertain to structural characteristics and
chemical properties of the allergenic substance (Landsteiner and Jacobs (5)).
Others pertain to certain characteristics or pathologic changes in the human
skin which is exposed to the allergenic substance. Among these are excessive or
inadequate sweat secretion, excessive or inadequate sebaceous secretions, presence
of inflammation or of devitalized tissue, lowered capacity to neutralize alkali
(Sulzberger (6)). However, to our knowledge there has been hitherto no evidence
suggesting the existence of a transferable factor which specifically favors active
sensitization to the substance to which the donor of the factor possesses an aller-
gic hypersensitivity.
SUMMARY
1. Passive transfer of eczematous allergic hypersensitivity was attempted by
the technic of H. S. Lawrence: suspensions of viable white cells from donors.
each one of which was known to have an eczematous allergic contact-type hy-
persensitivity to a specific allergen, were injected intracutaneously in recipients,
known not to be allergic to the particular allergen. Transfers of white cell sus-
pensions were carried out from 27 different donors. Among these were subjects
with allergic hypersensitivity to paraphenylenediamine, nickel sulfate, benzo-
caine, turpentine, ragweed oleoresin, mercury, Aquaphor and Surfacaine. The
recipients were patch tested at the site where the white cells had been injected
and at least at one control site.
2. The results of the patch tests were negative in 21 recipients and questionable
in two.
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3. The results of the patch tests were positive in 4 recipients. Three of these
had received white cells from donors allergic to turpentine and one from a donor
allergic to ammoniated mercury. However in all four subjects patch tests were
again positive on retesting 2 to 8 months later.
4. While these tests indicate that the attempt at passive transfer failed in the
large majority of cases, the evidence at hand is inadequate to decide whether the
sensitization was of the passively transferred type or whether it had been ac-
tively produced in the four recipients with positive tests. The possibility is con-
sidered that the white cells of patients with allergic eczematous hypersensitivity
to a specific allergen may contain a factor which, when injected intracutaneously
to non-sensitive subjects, increases their capacity to undergo active sensitization
upon exposure to the particular eczematogenic allergen.
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